Literature DB >> 33224825

A single-center retrospective analysis of childhood hepatoblastoma in China.

Wenya Yu1, Xiang Liu2, Jingquan Li1, Zhifeng Xi3, Jing Jin3, Hongting Huang3, Yang Ge1, Qiang Xia3.   

Abstract

BACKGROUND: This study aimed to investigate the critical factors associated with prognosis for children with hepatoblastoma (HB) in mainland China combined with the aspect of health economics and management.
METHODS: This study retrospectively reviewed children with HB in Renji Hospital Affiliated to the Shanghai Jiao Tong University School of Medicine from January 2013 to December 2019. Descriptive analysis was used to describe the essential characteristics. Kaplan-Meier method and Cox proportional hazard models were used to estimate the survival rate and prognosis factors.
RESULTS: For the 87 children with HB, the average survival was 2,002.8 days (95% CI: 1,798.7-2,206.9 days), the 1- and 5-year survival rates were 87.7% and 78.9%, respectively. Undergoing surgery and sex were independent prognostic factors of childhood HB. Children with HB undergoing hepatectomy (HR: 0.039) or liver transplantation (HR: 0.142) had a better prognosis, while boys were associated with a poorer prognosis (HR: 3.614). The average medical expenses for childhood HB were 40,217.5±3,862.0 CNY and liver transplantation cost more than hepatectomy.
CONCLUSIONS: The results had a comparable survival rate with other studies globally. Surgical therapy and sex are associated with the prognosis of children with HB. The economic burden of childhood HB deserves to be further explored. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Hepatoblastoma (HB); children; prognosis; survival

Year:  2020        PMID: 33224825      PMCID: PMC7667112          DOI: 10.21037/gs-20-710

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  51 in total

1.  Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma.

Authors:  A Carceller; H Blanchard; J Champagne; D St-Vil; A L Bensoussan
Journal:  J Pediatr Surg       Date:  2001-05       Impact factor: 2.545

2.  Liver transplantation for hepatic malignancies in children--we all need more information.

Authors:  Piotr Kaliciński; Jean Bernard Otte
Journal:  Pediatr Transplant       Date:  2009-09

Review 3.  Differential diagnosis and management of liver tumors in infants.

Authors:  Israel Fernandez-Pineda; Rosa Cabello-Laureano
Journal:  World J Hepatol       Date:  2014-07-27

Review 4.  SIOPEL trials using preoperative chemotherapy in hepatoblastoma.

Authors:  G Perilongo; E Shafford; J Plaschkes
Journal:  Lancet Oncol       Date:  2000-10       Impact factor: 41.316

5.  Surgical treatment of childhood hepatoblastoma in the Netherlands (1990-2013).

Authors:  Linde A D Busweiler; Marc H W A Wijnen; Jim C H Wilde; Egbert Sieders; Sheila E J Terwisscha van Scheltinga; L W Ernest van Heurn; Joseph Ziros; Roel Bakx; Hugo A Heij
Journal:  Pediatr Surg Int       Date:  2016-10-11       Impact factor: 1.827

6.  Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.

Authors:  J Brown; G Perilongo; E Shafford; J Keeling; J Pritchard; P Brock; C Dicks-Mireaux; A Phillips; A Vos; J Plaschkes
Journal:  Eur J Cancer       Date:  2000-07       Impact factor: 9.162

7.  Retrospective Analysis of Childhood Hepatoblastoma in a Single Centre in China.

Authors:  T Y Wang; Y L Han; Y J Gao; M Xu; S Gu; M Z Yin; Y M Zhong; W T Hu; C Pan; J Y Tang
Journal:  Clin Oncol (R Coll Radiol)       Date:  2019-04-15       Impact factor: 4.126

Review 8.  Hepatoblastoma clinical research: lessons learned and future challenges.

Authors:  Giorgio Perilongo; Marcio Malogolowkin; James Feusner
Journal:  Pediatr Blood Cancer       Date:  2012-06-07       Impact factor: 3.167

9.  Epidemiology of primary hepatic malignancies in U.S. children.

Authors:  Anil Darbari; Keith M Sabin; Craig N Shapiro; Kathleen B Schwarz
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

10.  Survival and analysis of prognostic factors for hepatoblastoma: based on SEER database.

Authors:  Tie-Cheng Feng; Hong-Yan Zai; Wei Jiang; Qin Zhu; Bo Jiang; Lei Yao; Xin-Ying Li; Zhi-Ming Wang
Journal:  Ann Transl Med       Date:  2019-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.